PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 87 filers reported holding PMV PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,245 | -34.9% | 8,509 | -33.7% | 0.00% | – |
| Q2 2023 | $80,310 | -46.9% | 12,829 | -59.5% | 0.00% | – |
| Q1 2023 | $151,195 | -46.6% | 31,697 | -2.6% | 0.00% | – |
| Q4 2022 | $283,002 | -26.1% | 32,529 | +1.1% | 0.00% | -100.0% |
| Q3 2022 | $383,000 | -18.5% | 32,186 | -2.3% | 0.00% | 0.0% |
| Q2 2022 | $470,000 | +8.3% | 32,960 | +58.1% | 0.00% | 0.0% |
| Q1 2022 | $434,000 | -20.8% | 20,847 | -12.1% | 0.00% | 0.0% |
| Q4 2021 | $548,000 | -21.3% | 23,727 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $696,000 | -43.6% | 23,362 | -35.4% | 0.00% | -50.0% |
| Q2 2021 | $1,235,000 | +81.6% | 36,166 | +75.0% | 0.00% | +100.0% |
| Q1 2021 | $680,000 | -46.5% | 20,662 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $1,271,000 | – | 20,662 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,869,911 | $115,323,000 | 47.76% |
| Euclidean Capital LLC | 2,769,813 | $82,540,000 | 40.12% |
| Logos Global Management LP | 1,400,000 | $41,720,000 | 3.01% |
| Orbimed Advisors | 7,330,423 | $218,447,000 | 2.40% |
| Boxer Capital, LLC | 2,268,236 | $67,593,000 | 2.36% |
| PERSONAL CFO SOLUTIONS, LLC | 355,342 | $10,589,000 | 2.17% |
| Asymmetry Capital Management, L.P. | 100,882 | $3,006,000 | 1.81% |
| Avoro Capital Advisors LLC | 2,925,000 | $87,165,000 | 1.37% |
| COMMODORE CAPITAL LP | 125,000 | $3,725,000 | 0.98% |
| HighVista Strategies LLC | 39,777 | $1,185,000 | 0.78% |